Featuring Amy Abernethy, M.D., Ph.D., principal deputy commissioner and acting CIO of the FDA.
In the digital age of healthcare, the U.S. Food and Drug Administration (FDA) is tasked with a difficult task: Approving safe and effective health tech, medical devices and digital health tools. As more entrants submit their technology to the agency, it is crucial that the federal regulator ensures the products will improve the lives of users.
At HLTH2019 in Las Vegas, Nevada, Amy Abernethy, M.D., Ph.D., principal deputy commissioner and acting CIO of the FDA, sat down with the hosts of Data Book to discuss how the agency creates new digital health guidances, the intersection of digital health and precision care, real-world data and the approach to approving new devices.
Connect with us on Twitter and let us know what you want to hear on Data Book this season.
Get the best insights in digital health directly to your inbox.
Binge More Data Book
Playing a Medical Video Game for CME Credit
A Closer Look at Pear Therapeutics